Sales of semaglutide products have soared in the past few years after the drug was shown to spur fast and significant weight loss.
consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe or effective.
The trouble is that those versions, often sold online, contain a version of semaglutide that is used in lab research and has not been approved for use in people. The drugs manufactured by Novo Nordisk include brands Ozempic and Rybelsus, used to treat diabetes, and Wegovy, approved to treat obesity.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns consumers not to use off-brand versions of Ozempic, WegovyConsumers should only use semaglutide prescribed by a health care provider and filled by a licensed pharmacy, FDA said.
Read more »
Ozempic Craze Has Spawned a Sketchy Black Market, FDA WarnsThe FDA has received adverse event reports from people using compounded semaglutide, which might not contain the same version of the popular obesity drug.
Read more »
Ozempic: Weight loss, side effects and potential to treat addictionThe drugs Ozempic and Wegovy can help people who are obese or overweight to quickly lose weight, but some are concerned they may cause hair loss or a gaunt appearance, dubbed 'Ozempic face'. What's the science behind the treatments?
Read more »
What is berberine, the supplement dubbed 'nature's Ozempic' on social media?As the dietary supplement berberine surges in popularity for its weight loss effects, here’s what to know about it, including how well it works and whether it’s safe.
Read more »
FDA warns about compounded versions of popular weight loss drugsFederal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products.
Read more »